Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) has a cash flow conversion efficiency ratio of 0.098x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs246.75 Million ≈ $2.67 Million USD) by net assets (Rs2.53 Billion ≈ $27.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JAGSNPHARM equity financing ratio to measure how much of total assets are equity-financed.
Jagsonpal Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Jagsonpal Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Jagsonpal Pharmaceuticals Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Jagsonpal Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jagsonpal Pharmaceuticals Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
HomesToLife Ltd
NASDAQ:HTLM
|
0.084x |
|
Paninvest Tbk
JK:PNIN
|
0.018x |
|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
-0.102x |
|
TrueBlue Inc
NYSE:TBI
|
-0.038x |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
0.247x |
|
Jean Co Ltd
TW:2442
|
0.583x |
|
MEDICLIN Aktiengesellschaft
XETRA:MED
|
0.097x |
|
Hanyang Securities Co Ltd
KO:001755
|
3.040x |
Annual Cash Flow Conversion Efficiency for Jagsonpal Pharmaceuticals Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Jagsonpal Pharmaceuticals Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see JAGSNPHARM market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.40 Billion ≈ $25.95 Million |
Rs553.00 Million ≈ $5.98 Million |
0.230x | +22.82% |
| 2024-03-31 | Rs1.87 Billion ≈ $20.27 Million |
Rs351.66 Million ≈ $3.80 Million |
0.188x | -36.09% |
| 2023-03-31 | Rs1.59 Billion ≈ $17.18 Million |
Rs466.54 Million ≈ $5.05 Million |
0.294x | +586.35% |
| 2022-03-31 | Rs1.31 Billion ≈ $14.15 Million |
Rs55.98 Million ≈ $605.41K |
0.043x | -81.52% |
| 2021-03-31 | Rs1.22 Billion ≈ $13.19 Million |
Rs282.22 Million ≈ $3.05 Million |
0.231x | +128.51% |
| 2020-03-31 | Rs1.11 Billion ≈ $12.01 Million |
Rs112.47 Million ≈ $1.22 Million |
0.101x | -65.75% |
| 2019-03-31 | Rs1.04 Billion ≈ $11.30 Million |
Rs308.98 Million ≈ $3.34 Million |
0.296x | +1940.07% |
| 2018-03-31 | Rs980.47 Million ≈ $10.60 Million |
Rs-15.76 Million ≈ $-170.43K |
-0.016x | +45.50% |
| 2017-03-31 | Rs1.10 Billion ≈ $11.89 Million |
Rs-32.41 Million ≈ $-350.56K |
-0.029x | -132.09% |
| 2016-03-31 | Rs983.64 Million ≈ $10.64 Million |
Rs90.39 Million ≈ $977.48K |
0.092x | +104.01% |
| 2015-03-31 | Rs954.26 Million ≈ $10.32 Million |
Rs42.98 Million ≈ $464.81K |
0.045x | -40.94% |
| 2014-03-31 | Rs985.89 Million ≈ $10.66 Million |
Rs75.18 Million ≈ $813.08K |
0.076x | -37.74% |
| 2013-03-31 | Rs983.71 Million ≈ $10.64 Million |
Rs120.50 Million ≈ $1.30 Million |
0.122x | +70.29% |
| 2012-03-31 | Rs984.69 Million ≈ $10.65 Million |
Rs70.83 Million ≈ $766.00K |
0.072x | +3.52% |
| 2011-03-31 | Rs929.14 Million ≈ $10.05 Million |
Rs64.56 Million ≈ $698.20K |
0.069x | +611.50% |
| 2010-03-31 | Rs875.70 Million ≈ $9.47 Million |
Rs8.55 Million ≈ $92.49K |
0.010x | -95.61% |
| 2009-03-31 | Rs801.68 Million ≈ $8.67 Million |
Rs178.16 Million ≈ $1.93 Million |
0.222x | +198.39% |
| 2008-03-31 | Rs750.34 Million ≈ $8.11 Million |
Rs55.88 Million ≈ $604.33K |
0.074x | +127.99% |
| 2007-03-31 | Rs724.98 Million ≈ $7.84 Million |
Rs23.68 Million ≈ $256.11K |
0.033x | +44.65% |
| 2006-03-31 | Rs702.35 Million ≈ $7.60 Million |
Rs15.86 Million ≈ $171.53K |
0.023x | -- |
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. … Read more